Logo image of R3NK.DE

RENK GROUP AG (R3NK.DE) Stock Fundamental Analysis

Europe - FRA:R3NK - DE000RENK730 - Common Stock

67.06 EUR
+4.25 (+6.77%)
Last: 11/13/2025, 10:54:09 AM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to R3NK. R3NK was compared to 109 industry peers in the Machinery industry. R3NK has an average financial health and profitability rating. While showing a medium growth rate, R3NK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year R3NK was profitable.
In the past year R3NK had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: R3NK reported negative net income in multiple years.
Each year in the past 5 years R3NK had a positive operating cash flow.
R3NK.DE Yearly Net Income VS EBIT VS OCF VS FCFR3NK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M 100M 150M

1.2 Ratios

The Return On Assets of R3NK (4.73%) is better than 66.97% of its industry peers.
R3NK has a better Return On Equity (18.78%) than 83.49% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.80%, R3NK is in the better half of the industry, outperforming 66.97% of the companies in the same industry.
R3NK had an Average Return On Invested Capital over the past 3 years of 5.23%. This is below the industry average of 8.90%.
The last Return On Invested Capital (7.80%) for R3NK is above the 3 year average (5.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.73%
ROE 18.78%
ROIC 7.8%
ROA(3y)2.22%
ROA(5y)0.83%
ROE(3y)8.35%
ROE(5y)2.21%
ROIC(3y)5.23%
ROIC(5y)3.81%
R3NK.DE Yearly ROA, ROE, ROICR3NK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

R3NK has a better Profit Margin (6.15%) than 69.72% of its industry peers.
R3NK has a Operating Margin of 11.20%. This is in the better half of the industry: R3NK outperforms 76.15% of its industry peers.
In the last couple of years the Operating Margin of R3NK has grown nicely.
The Gross Margin of R3NK (24.88%) is worse than 75.23% of its industry peers.
In the last couple of years the Gross Margin of R3NK has grown nicely.
Industry RankSector Rank
OM 11.2%
PM (TTM) 6.15%
GM 24.88%
OM growth 3Y23.67%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.17%
GM growth 5YN/A
R3NK.DE Yearly Profit, Operating, Gross MarginsR3NK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 -10 20

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), R3NK is creating some value.
R3NK has about the same amout of shares outstanding than it did 1 year ago.
R3NK has a better debt/assets ratio than last year.
R3NK.DE Yearly Shares OutstandingR3NK.DE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M
R3NK.DE Yearly Total Debt VS Total AssetsR3NK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 4.58 indicates that R3NK is not in any danger for bankruptcy at the moment.
R3NK has a Altman-Z score of 4.58. This is amongst the best in the industry. R3NK outperforms 88.07% of its industry peers.
R3NK has a debt to FCF ratio of 3.82. This is a good value and a sign of high solvency as R3NK would need 3.82 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.82, R3NK is doing good in the industry, outperforming 64.22% of the companies in the same industry.
R3NK has a Debt/Equity ratio of 1.29. This is a high value indicating a heavy dependency on external financing.
R3NK has a Debt to Equity ratio of 1.29. This is amonst the worse of the industry: R3NK underperforms 81.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 3.82
Altman-Z 4.58
ROIC/WACC1.08
WACC7.24%
R3NK.DE Yearly LT Debt VS Equity VS FCFR3NK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

R3NK has a Current Ratio of 1.90. This is a normal value and indicates that R3NK is financially healthy and should not expect problems in meeting its short term obligations.
R3NK has a better Current ratio (1.90) than 69.72% of its industry peers.
R3NK has a Quick Ratio of 1.90. This is a bad value and indicates that R3NK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.97, R3NK is in line with its industry, outperforming 50.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 0.97
R3NK.DE Yearly Current Assets VS Current LiabilitesR3NK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 125.37% over the past year.
The Revenue has grown by 21.91% in the past year. This is a very strong growth!
The Revenue has been growing by 17.80% on average over the past years. This is quite good.
EPS 1Y (TTM)125.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.36%
Revenue 1Y (TTM)21.91%
Revenue growth 3Y17.8%
Revenue growth 5YN/A
Sales Q2Q%27.47%

3.2 Future

Based on estimates for the next years, R3NK will show a very strong growth in Earnings Per Share. The EPS will grow by 34.63% on average per year.
The Revenue is expected to grow by 19.60% on average over the next years. This is quite good.
EPS Next Y63.05%
EPS Next 2Y45.99%
EPS Next 3Y39.68%
EPS Next 5Y34.63%
Revenue Next Year19.98%
Revenue Next 2Y19.15%
Revenue Next 3Y18.84%
Revenue Next 5Y19.6%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
R3NK.DE Yearly Revenue VS EstimatesR3NK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
R3NK.DE Yearly EPS VS EstimatesR3NK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

R3NK is valuated quite expensively with a Price/Earnings ratio of 87.09.
R3NK's Price/Earnings ratio is a bit more expensive when compared to the industry. R3NK is more expensive than 66.97% of the companies in the same industry.
R3NK is valuated expensively when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 35.48, which means the current valuation is very expensive for R3NK.
Compared to the rest of the industry, the Price/Forward Earnings ratio of R3NK indicates a slightly more expensive valuation: R3NK is more expensive than 77.06% of the companies listed in the same industry.
R3NK's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 34.43.
Industry RankSector Rank
PE 87.09
Fwd PE 35.48
R3NK.DE Price Earnings VS Forward Price EarningsR3NK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, R3NK is valued more expensive than 80.73% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of R3NK indicates a slightly more expensive valuation: R3NK is more expensive than 70.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 48.06
EV/EBITDA 30.8
R3NK.DE Per share dataR3NK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

R3NK's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of R3NK may justify a higher PE ratio.
R3NK's earnings are expected to grow with 39.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.38
PEG (5Y)N/A
EPS Next 2Y45.99%
EPS Next 3Y39.68%

0

5. Dividend

5.1 Amount

With a yearly dividend of 0.67%, R3NK is not a good candidate for dividend investing.
R3NK's Dividend Yield is slightly below the industry average, which is at 2.60.
Compared to an average S&P500 Dividend Yield of 2.36, R3NK's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.67%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
R3NK.DE Yearly Dividends per shareR3NK.DE Yearly Dividends per shareYearly Dividends per share 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

R3NK pays out 93.71% of its income as dividend. This is not a sustainable payout ratio.
DP93.71%
EPS Next 2Y45.99%
EPS Next 3Y39.68%
R3NK.DE Yearly Income VS Free CF VS DividendR3NK.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 50M 100M
R3NK.DE Dividend Payout.R3NK.DE Dividend Payout, showing the Payout Ratio.R3NK.DE Dividend Payout.PayoutRetained Earnings

RENK GROUP AG

FRA:R3NK (11/13/2025, 10:54:09 AM)

67.06

+4.25 (+6.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-13 2025-11-13
Inst Owners33.51%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.71B
Revenue(TTM)1.25B
Net Income(TTM)76.86M
Analysts77.27
Price Target70.58 (5.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.67%
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DP93.71%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.36%
Min EPS beat(2)-58.28%
Max EPS beat(2)43.56%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.44%
Min Revenue beat(2)-4.01%
Max Revenue beat(2)-0.86%
Revenue beat(4)1
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-4.01%
Max Revenue beat(4)7.09%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.32%
PT rev (3m)14.9%
EPS NQ rev (1m)1500%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.27%
EPS NY rev (3m)5.76%
Revenue NQ rev (1m)-0.48%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 87.09
Fwd PE 35.48
P/S 5.36
P/FCF 48.06
P/OCF 39.85
P/B 16.39
P/tB 87.29
EV/EBITDA 30.8
EPS(TTM)0.77
EY1.15%
EPS(NY)1.89
Fwd EY2.82%
FCF(TTM)1.4
FCFY2.08%
OCF(TTM)1.68
OCFY2.51%
SpS12.5
BVpS4.09
TBVpS0.77
PEG (NY)1.38
PEG (5Y)N/A
Graham Number8.42
Profitability
Industry RankSector Rank
ROA 4.73%
ROE 18.78%
ROCE 12.26%
ROIC 7.8%
ROICexc 8.57%
ROICexgc 12.6%
OM 11.2%
PM (TTM) 6.15%
GM 24.88%
FCFM 11.16%
ROA(3y)2.22%
ROA(5y)0.83%
ROE(3y)8.35%
ROE(5y)2.21%
ROIC(3y)5.23%
ROIC(5y)3.81%
ROICexc(3y)6.06%
ROICexc(5y)4.44%
ROICexgc(3y)10.07%
ROICexgc(5y)7.47%
ROCE(3y)8.22%
ROCE(5y)5.99%
ROICexgc growth 3Y40.48%
ROICexgc growth 5YN/A
ROICexc growth 3Y46.46%
ROICexc growth 5YN/A
OM growth 3Y23.67%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.17%
GM growth 5YN/A
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 3.82
Debt/EBITDA 2.42
Cap/Depr 37.04%
Cap/Sales 2.3%
Interest Coverage 4.4
Cash Conversion 77.31%
Profit Quality 181.53%
Current Ratio 1.9
Quick Ratio 0.97
Altman-Z 4.58
F-Score8
WACC7.24%
ROIC/WACC1.08
Cap/Depr(3y)34.27%
Cap/Depr(5y)51.64%
Cap/Sales(3y)2.93%
Cap/Sales(5y)4.71%
Profit Quality(3y)329.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)125.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.36%
EPS Next Y63.05%
EPS Next 2Y45.99%
EPS Next 3Y39.68%
EPS Next 5Y34.63%
Revenue 1Y (TTM)21.91%
Revenue growth 3Y17.8%
Revenue growth 5YN/A
Sales Q2Q%27.47%
Revenue Next Year19.98%
Revenue Next 2Y19.15%
Revenue Next 3Y18.84%
Revenue Next 5Y19.6%
EBIT growth 1Y50.94%
EBIT growth 3Y45.68%
EBIT growth 5YN/A
EBIT Next Year87.33%
EBIT Next 3Y41.78%
EBIT Next 5Y33.74%
FCF growth 1Y-9.06%
FCF growth 3Y29.47%
FCF growth 5YN/A
OCF growth 1Y-6.12%
OCF growth 3Y20.72%
OCF growth 5YN/A

RENK GROUP AG / R3NK.DE FAQ

What is the fundamental rating for R3NK stock?

ChartMill assigns a fundamental rating of 5 / 10 to R3NK.DE.


What is the valuation status for R3NK stock?

ChartMill assigns a valuation rating of 2 / 10 to RENK GROUP AG (R3NK.DE). This can be considered as Overvalued.


How profitable is RENK GROUP AG (R3NK.DE) stock?

RENK GROUP AG (R3NK.DE) has a profitability rating of 6 / 10.


How financially healthy is RENK GROUP AG?

The financial health rating of RENK GROUP AG (R3NK.DE) is 5 / 10.


Can you provide the expected EPS growth for R3NK stock?

The Earnings per Share (EPS) of RENK GROUP AG (R3NK.DE) is expected to grow by 63.05% in the next year.